As the identify implies these mutations are typically seen in clients who have unsuccessful and afterwards interrupted therapy with zidovudine (AZT) or stavudine (d4T), which sales opportunities to “reversion” of the resistance mutations T215Y and T215F, but practically nothing precludes
In vitro Angiogenesis Assay. HUVEC have been plated on basal membrane extract (10 mg/ml,...